Connect with us

District of Columbia

Medical Examiner: Two beloved D.C. gay men died of accidental drug ‘toxicity’

Christmas week deaths prompted response by LGBTQ community

Published

on

Shakers posted this Instagram message about a celebration of life for Brandon Roman and Robbie Barletta held in February.

The D.C. Office of the Chief Medical Examiner has confirmed for the Washington Blade that the cause of death of two widely known and beloved gay men found unconscious at one of their homes in Northwest D.C. on Dec. 27 was an accidental consumption of several drugs that created a fatal ‘toxic’ effect.

D.C. police and Fire and Emergency Medical Services Department reports show that prominent D.C. attorney and LGBTQ rights advocate Brandon Roman, 38, and historic preservation expert and home renovation business owner Robert “Robbie” Barletta, 28, were found unconscious when police and emergency medical personnel arrived on the afternoon of Dec. 27.  

The reports show that Roman was declared deceased at the scene shortly after D.C. police and an ambulance arrived at the house in response to a 911 call. According to one of the reports, Barletta was taken to Washington Hospital Center where he died on Dec. 29.

The D.C. gay bar Shakers hosted a celebration of life for the two men on Feb. 3, And people who knew them told the Blade their sudden and unexpected deaths prompted many in the community, including several gay bars, to take steps to address the overdose problem in the LGBTQ community, even though the cause of death of Roman and Barletta had not been confirmed at that time.

The Medical Examiner’s office lists the cause of death for Barletta as, “Cocaethylene, cocaine, fentanyl, and 3,4-methylenedioxymethanmphetamine toxicity.” It lists the manner of death as “Accident/Intoxication.”

It lists the cause of death for Roman as, “Combined toxic effects of 3,4-methylenedioxymethanphetamine, cocaethylene, cocaine, fentanyl, ketamine, and xylazine.” Like Barletta, it lists the manner of death for Roman as “Accident/Intoxication.”

A spokesperson for the Medical Examiner’s office didn’t immediately respond to a request by the Blade for an explanation of  whether one or more of the multiple drugs found in the two men’s bodies may have been the main cause of death.

The D.C. Department of Health and officials with health departments in other locations have said one of the leading causes of drug overdose deaths is fentanyl, which victims often do not know is present in other drugs, such as cocaine. 

The National Institutes of Health and the U.S. Drug Enforcement Administration state on their websites that cocaethylene is formed within the human body when someone consumes both cocaine and an alcoholic beverage. The write-ups say cocaethylene has a longer lasting and more intense psychoactive effect than just cocaine.

According to the NIH and DEA write-ups, 3,4-methylenedioxymethamphetamine, commonly known as ecstasy or MDMA, acts as a stimulant and hallucinogen, producing feelings of euphoria and is often used as a so-called party drug. The write-ups say ketamine has been used medically as an anesthetic but is also used as a party drug for its hallucinogenic and “dissociative sensations.”

The NIH and DEA write-ups say Xylazine, often called “tranq” or “tranq dope,” is a non-opioid sedative or tranquilizer approved for veterinary use but not for humans. The write-ups say it has been linked to a large number of drug overdose cases in humans, especially when used, most likely unintentionally, with fentanyl as a party drug. Because it is a non-opioid drug, the life-saving opioid overdose prevention medication naloxone or Narcan does not work to stop an overdose of Xylazine, the NIH write-up says.

Johnny Bailey, Community Outreach Coordinator for HIPS D.C., an LGBTQ-supportive  organization that provides services and support for those who use recreational drugs, said he strongly believes that Barletta and Roman did not intentionally consume some of the drugs found in their system.

“I’m going to say I do believe this was a poisoning,” Bailey told the Blade. “I think it unfair to call some things an overdose because an overdose is when you do too much of a drug and you die from that drug,” he said. “This is like if you have a few glasses of wine every night and someone puts arsenic in your wine, no one would be like, ‘oh, they drank themselves to death.’ They were poisoned. And that’s what I think is happening here,” he said in referring to Barletta and Roman.

D.C. police spokesperson Tom Lynch told the Blade in February that police were investigating the Barletta and Roman deaths, but investigators had to wait for the Medical Examiner’s official determination of the cause and manner of death before the investigation could fully proceed. He said the deaths were not being investigated as a homicide at that time.

Police and court records in D.C. and other jurisdictions show that police and prosecutors have filed criminal charges against drug dealers and suppliers in cases involving drug overdose deaths. In some cases, when the drug dealer is found they have been charged with manslaughter, reckless endangerment, or related charges.

When contacted this week to ask about the status of the D.C. police investigation into the Barletta and Roman deaths now that the Medical Examiner has determined the cause and manner of death, Lynch declined further comment.

“The investigation into these deaths remains open,” he said. “There are no updates on the investigation that we are ready to release to the public.”

Bailey said in January that one development that has emerged from the Barletta-Roman deaths is a stepped-up effort to raise awareness of the problem and support by LGBTQ bars in D.C. to host training sessions and to distribute the lifesaving Narcan treatment nasal spray as well as fentanyl test kits. 

“It’s horrible when it takes a tragedy for things to come together,” Bailey said. “But this tragedy has truly triggered a powerful response. It was a real wakeup call for a lot of people.”

He said the local gay bars Trade, Pitchers, and JR.’s are among the LGBTQ bars that have hosted training sessions or tables set up by HIPS to provide related information along with test kits and Narcan.

According to Bailey, HIPS is partnering with Whitman-Walker Health, D.C.’s LGBTQ supportive health care center, to officially launch on April 5 a new Harm Reduction Vending Machine Project, “that seeks to put free harm reduction/overdose prevention supplies in areas with high rates of overdose deaths and other barriers to care.” The launch event will take place at Whitman-Walker’s Max Robinson Center in Southeast D.C.

Advertisement
FUND LGBTQ JOURNALISM
SIGN UP FOR E-BLAST

District of Columbia

Norton hailed as champion of LGBTQ rights

D.C. congressional delegate to retire after 36 years in U.S. House

Published

on

Del. Eleanor Holmes Norton announced she will not seek re-election; her term ends January 2027. (Washington Blade file photo by Drew Brown)

LGBTQ rights advocates reflected on D.C. Congressional Del. Eleanor Holmes Norton’s longstanding advocacy and support for LGBTQ rights in Congress following her decision last month not to run for re-election this year. 

Upon completing her current term in office in January 2027, Norton, a Democrat, will have served 18 two-year terms and 36 years in her role as the city’s non-voting delegate to the U.S. House.

LGBTQ advocates have joined city officials and community leaders in describing Norton as a highly effective advocate for D.C. under the city’s limited representation in Congress where she could not vote on the House floor but stood out in her work on House committees and moving, powerful speeches on the House floor.

 “During her more than three decades in Congress, Eleanor Holmes Norton has been a champion for the District of Columbia and the LGBTQ+ community,” said David Stacy, vice president of government affairs for the Human Rights Campaign, the D.C.-based national LGBTQ advocacy organization.

“When Congress blocked implementation of D.C.’s domestic partnership registry, Norton led the fight to allow it to go into effect,” Stacey said. “When President Bush tried to ban marriage equality in every state and the District, Norton again stood up in opposition. And when Congress blocked HIV prevention efforts, Norton worked to end that interference in local control,” he said.

Del. Eleanor Holmes Norton (D-D.C.) (Washington Blade photo by Jeff Surprenant)

In reflecting the sentiment of many local and national LGBTQ advocates familiar with Norton’s work, Stacy added, “We have been lucky to have such an incredible champion. As her time in Congress comes to an end, we honor her extraordinary impact in the nation’s capital and beyond by standing together in pride and gratitude.”

Norton has been among the lead co-sponsors and outspoken supporters of LGBTQ rights legislation introduced in Congress since first taking office, including the currently pending Equality Act, which would ban employment discrimination based on sexual orientation and gender identity. 

Activists familiar with Norton’s work also point out that she has played a lead role in opposing and helping to defeat anti-LGBTQ legislation. In 2018, Norton helped lead an effort to defeat a bill called the First Amendment Defense Act introduced by U.S. Sen. Mike Lee (R-Utah), which Norton said included language that could “gut” D.C.’s Human Rights Act’s provisions banning LGBTQ discrimination.

Norton pointed to a provision in the bill not immediately noticed by LGBTQ rights organizations that would define D.C.’s local government as a federal government entity and allow potential discrimination against LGBTQ people based on a “sincerely held religious belief.”

“This bill is the latest outrageous Republican attack on the District, focusing particularly on our LGBT community and the District’s right to self-government,” Norton said shortly after the bill was introduced. “We will not allow Republicans to discriminate against the LGBT community under the guise of religious liberty,” she said. Records show supporters have not secured the votes to pass it in several congressional sessions.

In 2011, Norton was credited with lining up sufficient opposition to plans by some Republican lawmakers to attempt to overturn D.C.’s same-sex marriage law, that the Council passed and the mayor signed in 2010.   

In 2015, Norton also played a lead role opposing attempts by GOP members of  Congress to overturn another D.C. law protecting LGBTQ students at religious schools, including the city’s Catholic University, from discrimination such as the denial of providing meeting space for an LGBTQ organization.

More recently, in 2024 Norton again led efforts to defeat an attempt by Republican House members to amend the D.C. budget bill that Congress must pass to eliminate funding for the Mayor’s Office of LGBTQ Affairs and to prohibit the city from using its funds to enforce the D.C. Human Rights Act in cases of discrimination against transgender people.

“The Republican amendment that would prohibit funds from being used to enforce anti-LGBTQ+ discrimination regulations and the amendment to defund the Mayor’s Office of LGBTQ+ Affairs are disgraceful attempts, in themselves, to discriminate against D.C.’s LGBTQ+ community while denying D.C. residents the limited governance over their local affairs to which they are entitled,” Norton told the Washington Blade.

In addition to pushing for LGBTQ supportive laws and opposing anti-LGBTQ measures Norton has spoken out against anti-LGBTQ hate crimes and called on the office of the U.S. Attorney for D.C. in 2020 to more aggressively prosecute anti-LGBTQ hate crimes.

Del. Eleanor Holmes Norton marches in the 1995 AIDS Walk. (Washington Blade archive photo by Clint Steib)

“There is so much to be thankful for Eleanor Holmes Norton’s many years of service to all the citizens and residents of the District of Columbia,” said John Klenert, a member of the board of the LGBTQ Victory Fund. “Whether it was supporting its LGBTQ+ people for equal rights, HIV health issues, home rule protection, statehood for all 700,000 people, we could depend on her,” he said.

Ryan Bos, executive director of Capital Pride Alliance, the group that organizes D.C.’s annual LGBTQ Pride events, called Norton a “staunch” LGBTQ community ally and champion for LGBTQ supportive legislation in Congress.

“For decades, Congresswoman Norton has marched in the annual Capital Pride Parade, showing her pride and using her platform to bring voice and visibility in our fight to advance civil rights, end discrimination, and affirm the dignity of all LGBTQ+ people” Bos said. “We will be forever grateful for her ongoing advocacy and contributions to the LGBTQ+ movement.”

Howard Garrett, president of D.C.’s Capital Stonewall Democrats, called Norton a “consistent and principled advocate” for equality throughout her career. “She supported LGBTQ rights long before it was politically popular, advancing nondiscrimination protections and equal protection under the law,” he said.

“Eleanor was smart, tough, and did not suffer fools gladly,” said Rick Rosendall, former president of the D.C. Gay and Lesbian Activists Alliance. “But unlike many Democratic politicians a few decades ago who were not reliable on LGBTQ issues, she was always right there with us,” he said. “We didn’t have to explain our cause to her.”

Longtime D.C. gay Democratic activist Peter Rosenstein said he first met Norton when she served as chair of the New York City Human Rights Commission. “She got her start in the civil rights movement and has always been a brilliant advocate for equality,” Rosenstein said.

“She fought for women and for the LGBTQ community,” he said. “She always stood strong with us in all the battles the LGBTQ community had to fight in Congress. I have been honored to know her, thank her for her lifetime of service, and wish her only the best in a hard-earned retirement.”

Continue Reading

District of Columbia

D.C. Council urged to improve ‘weakened’ PrEP insurance bill

AIDS group calls for changes before full vote on Feb. 3

Published

on

HIV + HEP Policy Institute Executive Director Carl Schmid. (Photo courtesy of Schmid)

The D.C.-based HIV + Hepatitis Policy Institute is calling on the D.C. Council to reverse what it says was the “unfortunate” action by a Council committee to weaken a bill aimed at requiring health insurance companies to cover the costs of HIV prevention or PrEP drugs for D.C. residents at risk for HIV infection.

HIV + HEP Policy Institute Executive Director Carl Schmid points out in a Jan. 30 email message to all 13 D.C. Council members that the Council’s Committee on Health on Dec. 8, 2025, voted to change the PrEP DC Act of 2025, Bill 26-0159, to require insurers to fully cover only one PrEP drug regimen.

Schmid noted the bill as originally written and introduced Feb. 28, 2025, by Council member Zachary Parker (D-Ward 5), the Council’s only gay member, required insurers to cover all PrEP drugs, including the newest PrEP medication taken by injection once every six months. 

Schmid’s message to the Council members was sent on Friday, Jan. 30, just days before the Council was scheduled to vote on the bill on Feb. 3. He contacted the Washington Blade about his concerns about the bill as changed by committee that same day.

 Spokespersons for Parker and the Committee on Health and its chairperson, Council member Christina Henderson (I-At-Large) didn’t immediately respond to the Blade’s request for comment on the issue, saying they were looking into the matter and would try to provide a response on Monday, Jan. 2.

 In his message to Council members, Schmid also noted that he and other AIDS advocacy groups strongly supported the committee’s decision to incorporate into the bill a separate measure introduced by Council member Brooke Pinto (D-Ward 2) that would prohibit insurers, including life insurance companies, from denying coverage to people who are on PrEP.

“We appreciate the Committee’s revisions to the bill that incorporates Bill 26-0101, which prohibits discrimination by insurance carriers based on PrEP use,” Schmid said in his statement to all Council members.

 “However, the revised PrEP coverage provision would actually reduce PrEP options for D.C. residents that are required by current federal law, limit patient choice, and place D.C. behind states that have enacted HIV prevention policies designed to remain in effect regardless of any federal changes,” Schmid added.

He told the Washington Blade that although these protections are currently provided through coverage standards recommended in the U.S. Affordable Care Act, AIDS advocacy organizations have called for D.C. and states to pass their own legislation requiring insurance coverage of PrEP in the event that the federal policies are weakened or removed by the Trump administration, which has already reduced or ended federal funding for HIV/AIDS-related programs.

“The District of Columbia has always been a leader in the fight against HIV,” Schmid said in a statement to Council members. But in a separate statement he sent to the Blade, Schmid said the positive version of the bill as introduced by Parker and the committee’s incorporation of the Pinto bill were in stark contrast to the “bad side  — the bill would only require insurers to cover one PrEP drug.” 

He added, “That is far worse than current federal requirements. Obviously, the insurers got to them.”

  The Committee on Health’s official report on the bill summarizes testimony in support of the bill by health-related organizations, including Whitman-Walker Health, and two D.C. government officials before the committee at an Oct. 30, 2025, public hearing.

 Among them were Clover Barnes, Senior Deputy Director of the D.C. HIV/AIDS, Hepatitis, STD, and TB Administration, and Philip Barlow, Associate Commissioner for the D.C. Department of Insurance, Securities, and Banking.

Although both Barnes and Barlow expressed overall support for the bill, Barlow suggested several changes, one of which could be related to the committee’s change of the bill described by Schmid, according to the committee report.  

“First, he recommended changing the language that required PrEP and PEP coverage by insurers to instead require that insurers who already cover PrEP and PEP do not impose cost sharing or coverage more restrictive than other treatments,” the committee report states. “He pointed out that D.C. insurers already cover PrEP and PEP as preventive services, and this language would avoid unintended costs for the District,” the report adds.

PEP refers to Post-Exposure Prophylaxis medication, while PrEP stands for Pre-Exposure Prophylaxis medication.

 In response to a request from the Blade for comment, Daniel Gleick, Mayor Muriel Bowser’s press secretary, said he would inquire about the issue in the mayor’s office.

Naseema Shafi, Whitman-Walker Health’s CEO, meanwhile, in response to a request by the Blade for comment, released a statement sharing Schmid’s concerns about the current version of the PrEP DC Act of 2025, which the Committee on Health renamed as the PrEP DC Amendment Act of 2025.

 “Whitman-Walker Health believes that all residents of the District of Columbia should have access to whatever PrEP method is best for them based on their conversations with their providers,” Shafi said. “We would not want to see limitations on what insurers would cover,” she added. “Those kinds of limitations lead to significantly reduced access and will be a major step backwards, not to mention undermining the critical progress that the Affordable Care Act enabled for HIV prevention,” she said.     

 The Blade will update this story as soon as additional information is obtained from the D.C. Council members involved with the bill, especially Parker. The Blade will report on whether the full Council makes the changes to the bill requested by Schmid and others before it votes on whether to approve it at its Feb. 3 legislative session. 

Continue Reading

District of Columbia

Eleanor Holmes Norton ends 2026 reelection campaign

Longtime LGBTQ rights supporter introduced, backed LGBTQ-supportive legislation

Published

on

Congresswoman Eleanor Holmes Norton (D-D.C.) in 2023. (Washington Blade photo by Michael Key)

The reelection campaign for D.C. Congressional Delegate Eleanor Holmes Norton, who has been an outspoken supporter of LGBTQ rights since first taking office in 1991, filed a termination report on Jan. 25 with the Federal Elections Commission, indicating she will not run for a 19th term in the U.S. House of Representatives.

Norton’s decision not to run again, which was first reported by the online news publication NOTUS, comes at a time when many of her longtime supporters questioned her ability to continue in office at the age of 88.

NOTUS cited local political observers who pointed out that Norton has in the past year or two curtailed public appearances and, according to critics, has not taken sufficient action to oppose efforts by the Trump-Vance administration and Republican members of Congress to curtail D.C.’s limited home rule government.  

Those same critics, however, have praised Norton for her 35-year tenure as the city’s non-voting delegate in the House and as a champion for a wide range of issues of interest to D.C. LGBTQ rights advocates have also praised her longstanding support for LGBTQ rights issues both locally and nationally.

D.C. gay Democratic Party activist Cartwright Moore, who has worked on Norton’s congressional staff from the time she first took office in 1991 until his retirement in 2021, points out that Norton’s role as a staunch LGBTQ ally dates back to the 1970s when she served as head of the New York City Commission on Human Rights.  

“The congresswoman is a great person,” Moore told the Washington Blade in recounting his 30 years working on her staff, most recently as senior case worker dealing with local constituent issues.

Norton has been among the lead co-sponsors and outspoken supporters of LGBTQ rights legislation introduced in Congress since first taking office, including the currently pending Equality Act, which would ban employment discrimination based on sexual orientation and gender identity.  

She has introduced multiple LGBTQ supportive bills, including her most recent bill introduced in June 2025, the District of Columbia Local Juror Non-Discrimination Act, which would ban D.C. residents from being disqualified from jury service in D.C. Superior Court based on their sexual orientation or gender identity.

For many years, Norton has marched in the city’s annual Pride parade.

gay events dc, gay news, Washington Blade
Congresswoman Eleanor Holmes Norton (D-D.C.) participates in the city’s 2019 Capital Pride Parade. (Washington Blade photo by Drew Brown)

Her decision not to run for another term in office also comes at a time when, for the first time in many years, several prominent candidates emerged to run against her in the June 2026 D.C. Democratic primary. Among them are D.C. Council members Robert White (D-At-Large) and Brooke Pinto (D-Ward 2).

Others who have announced their candidacy for Norton’s seat include Jacque Patterson, president of the D.C. State Board of Education; Kinney Zalesne, a local Democratic party activist; and Trent Holbrook, who until recently served as Norton’s senior legislative counsel.

“For more than three decades, Congresswoman Norton has been Washington, D.C.’s steadfast warrior on Capitol Hill, a relentless advocate for our city’s right to self-determination, full democracy, and statehood,” said Oye Owolewa, the city’s elected U.S. shadow representative in a statement. “At every pivotal moment, she has stood firm on behalf of D.C. residents, never wavering in her pursuit of justice, equity, and meaningful representation for a city too often denied its rightful voice,” he said.

A spokesperson for Norton’s soon-to-close re-election campaign couldn’t immediately be reached for a comment by Norton on her decision not to seek another term in office. 

Continue Reading

Popular